Antesera to the ganglioside GM1 do not have anti-myelin or anti-axon activities in vitro
- 1 January 1989
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 478 (1) , 175-180
- https://doi.org/10.1016/0006-8993(89)91493-5
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Antisera to an Axolemma‐Enriched Fraction Have Antiaxon and Antimyelin Effects in VitroaAnnals of the New York Academy of Sciences, 1988
- Gangliosides GM1 and GD1b are antigens for IgM M-protein in a patientwith motor neuron diseaseNeurology, 1986
- Antisera to an axolemma-enriched fraction inhibit neurite outgrowth and destroy axons in vitroBrain Research, 1986
- Schwann Cell Marker Defined by a Monoclonal Antibody (224–58) with Species Cross‐Reactivity. II. Molecular Characterization of the EpitopeJournal of Neurochemistry, 1986
- Immune Reactivity Against Membranes Containing Ganglioside GM1in Chronic-Progressive Multiple Sclerosis: Observation by Spin-Membrane ImmunoassayImmunological Communications, 1984
- Characterization of an antiserum against an axolemma-enriched fractionJournal of Neuroimmunology, 1984
- Anti-ganglioside antibodies in multiple sclerosisJournal of the Neurological Sciences, 1980
- Synthetic Galactocerebrosides Evoke Myelination-Inhibiting AntibodiesScience, 1977
- Biosynthesis and Function of GangliosidesScience, 1976
- Enhanced afferent synaptic functions in fetal mouse spinal cord-sensory ganglion explants following NGF-induced ganglion hypertrophyBrain Research, 1974